Goss, G.Felip, E.Cobo, M.Lu, S.Syrigos, K.Lee, K. H.Goker, E.Georgoulias, V.Li, W.Guclu, S.Isla, D.Min, Y. JooMorabito, A.Ardizzoni, A.Gadgeel, S.Gibson, N.Kraemer, N.Solca, F.Cseh, A.Ehrnrooth, E.Soria, J.2019-10-272019-10-2720171556-08641556-1380https://doi.org/10.1016/j.jtho.2017.09.1484https://hdl.handle.net/11454/31561en10.1016/j.jtho.2017.09.1484info:eu-repo/semantics/openAccessNSCLCSquamous cell carcinomaafatinibImpact of ErbB Mutations on Clinical Outcomes in Afatinib- or Erlotinib-Treated Patients with SCC of the LungConference Object1211S2217S2218WOS:000463860802083Q1